Drug-coated balloons and in-stent restenosis: a new tale of an old story

EuroIntervention 2017;13:386-387 - DOI: 10.4244/EIJV13I4A60.

Roberto Nerla
Roberto Nerla, MD; Antonio Micari, MD, PhD; Alberto Cremonesi*, MD
Interventional Cardiology Unit, Maria Cecilia Hospital, Cotignola, Italy

Multiple studies have shown that nitinol stents improve patency and relieve symptoms more effectively when treating femoral and popliteal obstructions than percutaneous transluminal angioplasty (PTA) alone. However, it is now well known that stents in the superficial femoral artery (SFA) and popliteal arteries are subject to external forces such as bending, twisting, elongation, foreshortening, and external compression1. As a consequence, in-stent restenosis (ISR) has been reported to occur in up to 40% of femoropopliteal lesions treated with metallic stents within one year2,3, with the risk of ISR increasing with lesion length. As the population with femoropopliteal stenting continues to increase, ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Peripheral interventionsBelow the kneeIliac / Femoral / PoplitealStents, devices and techniquesStents, devices and techniques
Read next article
Working together today for the future: the EAPCI general assembly 2017

Latest news